Clinical Signs and Symptoms
ORPHA:227982 Autoimmune polyendocrinopathy type 3
The phenotypic description of this disease is based on an analysis of the biomedical literature and uses the terms of the Human Phenotype Ontology (HPO). Phenotypic abnormalities are presented by order of frequency of occurrence in the patient population, then by alphabetical order inside each frequency group.
- Autoimmunity HP:0002960
Always present
- Autoimmune antibody positivity HP:0030057
- Celiac disease HP:0002608
- Chronic atrophic gastritis HP:0002582
- Graves disease HP:0100647
- Hashimoto thyroiditis HP:0000872
- Macrocytic anemia HP:0001972
- Type I diabetes mellitus HP:0100651
Frequent
- Alopecia HP:0001596
- Anterior pituitary dysgenesis HP:0010625
- Biliary cirrhosis HP:0002613
- Decreased antibody level in blood HP:0004313
- Leukopenia HP:0001882
- Vitiligo HP:0001045
Occasional
- Abnormal blistering of the skin HP:0008066
- Antiphospholipid antibody positivity HP:0003613
- Aplasia/Hypoplasia of the spleen HP:0010451
- Autoimmune hypoparathyroidism HP:0011771
- Autoimmune thrombocytopenia HP:0001973
- Central diabetes insipidus HP:0000863
- Hepatitis HP:0012115
- Hypergonadotropic hypogonadism HP:0000815
- Interstitial pulmonary abnormality HP:0006530
- Iridocyclitis HP:0001094
- Keratoconjunctivitis sicca HP:0001097
- Non-caseating epithelioid cell granulomatosis HP:0012220
- Osteopenia HP:0000938
- Rheumatoid arthritis HP:0001370
- Thymoma HP:0100522
- Tubulointerstitial nephritis HP:0001970
- Xerostomia HP:0000217
Rare
- Chronic mucocutaneous candidiasis HP:0002728
- Primary adrenal insufficiency HP:0008207
Additional information
Further information
Specialised Social Services
Warning
The information provided is based on published scientific articles.
The information provided is estimated for the entire population of patients in routine care. Some phenotypic abnormalities reported here may occur individually with a variable temporality or severity, while others, not listed, may still be encountered. Phenotypic annotations are not yet available for all rare diseases; the annotation process is ongoing.
The information contained in Orphanet is regularly updated. It is possible that discoveries have been made since the last update and have not yet been incorporated.
Professionals are encouraged to always consult the latest scientific publications before making a decision based on the information provided. The information contained in Orphanet is not intended to replace the services of a healthcare professional. Orphanet cannot be held responsible for the deleterious, truncated or erroneous use of any information found in the Orphanet database.